Regulatory

Regulatory  ·  Weekly Digest 01 March to 07 March 2025
Celltrion receives FDA Phase 1 IND approval for next-generation ADC drug ‘CT-P70’

Weekly Digest – March 2025 Weekly Digest – March 2025 05 Mar 2025: Celltrion receives FDA Phase 1 IND approval for next-generation ADC Drug ‘CT-P70’ Celltrion received FDA approval for an Investigational New Drug (IND) application for its antibody-drug conjugate […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 01 March to 07 March 2025
Enhertu recommended for approval in the EU by CHMP for patients with HER2-low or HER2-ultralow metastatic breast cancer following at least one endocrine therapy

Weekly Digest – March 2025 Weekly Digest – March 2025 28 Feb 2025: Enhertu recommended for approval in the EU by CHMP for patients with HER2-low or HER2-ultralow metastatic breast cancer following at least one endocrine therapy Enhertu has been […]

by Sandhya Ramalingam

Continue Reading